Meeting the Demand for Renal Replacement Therapy during the COVID-19 Pandemic: A Manufacturer's Perspective

Michael S Anger; Claudy Mullon; Linda H Ficociello; David Thompson; Michael A Kraus; Pete Newcomb; Robert J Kossmann

doi:10.34067/KID.0006192020

Meeting the Demand for Renal Replacement Therapy during the COVID-19 Pandemic: A Manufacturer's Perspective

Kidney360. 2020 Dec 29;2(2):350-354. doi: 10.34067/KID.0006192020. eCollection 2021 Feb 25.

Authors

Michael S Anger¹, Claudy Mullon¹, Linda H Ficociello¹, David Thompson¹, Michael A Kraus², Pete Newcomb³, Robert J Kossmann¹

Affiliations

¹ Renal Therapies Group, Medical Department, Fresenius Medical Care, Waltham, Massachusetts.
² Fresenius Kidney Care, Medical Office, Fresenius Medical Care North America, Waltham, Massachusetts.
³ NxStage, Critical Care, Fresenius Medical Care, Lawrence, Massachusetts.

No abstract available

Keywords: AKI; COVID-19; CRRT; acute kidney injury and ICU nephrology; dialysis; dialysis machines; emergency response; manufacturer; manufacturing.

Publication types

Research Support, Non-U.S. Gov't

MeSH terms

Acute Kidney Injury* / epidemiology
COVID-19*
Continuous Renal Replacement Therapy*
Humans
Pandemics
Renal Replacement Therapy